Legal Representation
Attorney
Jenevieve Maerker, Esq.
USPTO Deadlines
Application History
41 eventsDate | Code | Type | Description |
---|---|---|---|
Dec 10, 2018 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Dec 10, 2018 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
May 1, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Apr 30, 2018 | EX5G | S | SOU EXTENSION 5 GRANTED |
Apr 25, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Apr 25, 2018 | EXT5 | S | SOU EXTENSION 5 FILED |
Apr 18, 2018 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Dec 7, 2017 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Dec 7, 2017 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Nov 3, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Nov 1, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Nov 1, 2017 | EXT4 | S | SOU EXTENSION 4 FILED |
Nov 1, 2017 | EX4G | S | SOU EXTENSION 4 GRANTED |
Apr 21, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Apr 19, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Apr 19, 2017 | EXT3 | S | SOU EXTENSION 3 FILED |
Apr 19, 2017 | EX3G | S | SOU EXTENSION 3 GRANTED |
Nov 18, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Nov 17, 2016 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Nov 17, 2016 | EX2G | S | SOU EXTENSION 2 GRANTED |
Nov 2, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Nov 2, 2016 | EXT2 | S | SOU EXTENSION 2 FILED |
Apr 16, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Apr 14, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Apr 14, 2016 | EXT1 | S | SOU EXTENSION 1 FILED |
Apr 14, 2016 | EX1G | S | SOU EXTENSION 1 GRANTED |
Nov 3, 2015 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Sep 8, 2015 | PUBO | A | PUBLISHED FOR OPPOSITION |
Sep 8, 2015 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Aug 19, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Aug 1, 2015 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Jul 31, 2015 | ALIE | A | ASSIGNED TO LIE |
Jul 20, 2015 | DOCK | D | ASSIGNED TO EXAMINER |
Jul 20, 2015 | DOCK | D | ASSIGNED TO EXAMINER |
Jul 20, 2015 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Jul 20, 2015 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
Jul 20, 2015 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Jul 20, 2015 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Jul 20, 2015 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Apr 20, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Apr 14, 2015 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma; pharmaceutical preparations for the treatment of ocular diseases and conditions, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Sustained drug delivery systems for ocular drugs
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
010